CYP19A1 and breast carcinoma: A more recent review by Seth et al., along with these data, presents more extensive information obtained on breast cancer cells’ cultures and drives the conclusion that flavonoids can inhibit aromatase and thus prevent estrogen binding to ERα through the inactivation of aromatase downstream pathways and ultimately lowering cancer cell proliferation [46].